日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Prevalence and Factors Associated with Premature Ejaculation in Japan: First Nationwide Cross-Sectional Survey by the Japanese Society for Sexual Medicine

日本性医学会首次全国横断面调查：早泄的患病率及相关因素

期刊:World Journal of Mens Health
影响因子:4.1
doi:10.5534/wjmh.250094
Shirai, Masato; Tsujimura, Akira; Fukuhara, Shinichiro; Chiba, Koji; Yoshizawa, Tsuyoshi; Tomoe, Hikaru; Kimura, Kazunori; Kikuchi, Eiji; Maeda, Eri; Sato, Yoshikazu; Nagai, Atsushi; Nagao, Koichi; Sasaki, Haruaki
发表日期：2026
文献求助 收藏

Pan-Asian subgroup analysis of EV-302/KEYNOTE-A39: a phase 3 study to evaluate enfortumab vedotin and pembrolizumab in patients with untreated advanced urothelial carcinoma

EV-302/KEYNOTE-A39 泛亚洲亚组分析：一项评估恩福妥单抗和帕博利珠单抗治疗未经治疗的晚期尿路上皮癌患者的 3 期研究

期刊:International Journal of Clinical Oncology
影响因子:2.8
doi:10.1007/s10147-025-02950-8
Kikuchi, Eiji; Van der Heijden, Michiel S; Valderrama, Begoña P; Gupta, Shilpa; Bedke, Jens; Shin, Sang Joon; Li, Jian-Ri; Guo, Jun; Danchaivijitr, Pongwut; Kanesvaran, Ravindran; Park, Se Hoon; Su, Wen-Pin; Kandori, Shuya; Bae, Woo Kyun; Wong, Alvin; Gorla, Seema; Bavle, Abhishek; Yu, Xuesong; Lu, Yi-Tsung; Powles, Thomas
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

How enfortumab vedotin plus pembrolizumab affects the quality of life of people with advanced urothelial cancer compared with platinum-based chemotherapy: a plain language summary of patient-reported outcomes from the EV-302 study

与铂类化疗相比，恩福妥单抗联合帕博利珠单抗治疗对晚期尿路上皮癌患者生活质量的影响：EV-302 研究患者报告结局的简明语言总结

期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2026.2645984
Gupta, Shilpa; Loriot, Yohann; Van der Heijden, Michiel S; Bedke, Jens; Valderrama, Begoña P; Kikuchi, Eiji; Fléchon, Aude; Petrylak, Daniel; De Santis, Maria; Galsky, Matthew D; Lee, Jae Lyun; Swami, Umang; Sridhar, Srikala S; De Giorgi, Ugo; Wright, Phoebe; Shih, Vanessa; Lu, Yi-Tsung; Guan, Xuesong; Dillon, Ryan; Shetty, Aditya; Homet Moreno, Blanca; Beaumont, Jennifer L; Purnajo, Intan; McManus, Shauna; Powles, Thomas
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Comparison of clinical outcomes between metallic and polymeric ureteral stents in malignant ureteral obstruction: a retrospective comparative study

恶性输尿管梗阻中金属支架与聚合物支架临床疗效的比较：一项回顾性比较研究

期刊:BMC Urology
影响因子:1.9
doi:10.1186/s12894-026-02062-z
Nishi, Tomohiro; Nakazawa, Ryuto; Morimoto, Yuki; Yamada, Ryuji; Tsukada, Hikaru; Shirai, Daisuke; Yoza, Naoto; Aida, Koichiro; Kikuchi, Eiji
发表日期：2026
文献求助 收藏

Erectile Function and Sexual Activity Are Declining in the Younger Generation: Results from a National Survey in Japan

日本一项全国性调查显示，年轻一代的勃起功能和性生活频率正在下降。

期刊:World Journal of Mens Health
影响因子:4.1
doi:10.5534/wjmh.240137
Tsujimura, Akira; Fukuhara, Shinichiro; Chiba, Koji; Yoshizawa, Tsuyoshi; Tomoe, Hikaru; Shirai, Masato; Kimura, Kazunori; Kikuchi, Eiji; Maeda, Eri; Sato, Yoshikazu; Nagai, Atsushi; Nagao, Koichi; Sasaki, Haruaki
发表日期：2025
文献求助 收藏

JAVEMACS-D: claims database analysis of avelumab maintenance therapy for advanced urothelial carcinoma in Japan

JAVEMACS-D：日本晚期尿路上皮癌avelumab维持治疗的索赔数据库分析

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-25515-1
Kobayashi, Takashi; Kitamura, Hiroshi; Furukawa, Yuka; Shono, Michihiro; Ito, Takayuki; Kikuchi, Eiji
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

A Multicenter Retrospective Study of Avelumab First-Line Maintenance and Subsequent Therapies for Locally Advanced and Metastatic Urothelial Carcinoma: Subgroup Analysis of First-Line Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, and Gemcitabine Plus Cisplatin in the Japan AVElumab MAintenance and Continuous Treatment Study (JAVEMACS)

一项针对局部晚期和转移性尿路上皮癌患者进行 Avelumab 一线维持治疗及后续治疗的多中心回顾性研究：日本 AVElumab 维持和持续治疗研究 (JAVEMACS) 中一线剂量密集型甲氨蝶呤、长春碱、多柔比星和顺铂以及吉西他滨联合顺铂方案的亚组分析

期刊:Current Oncology
影响因子:3.4
doi:10.3390/curroncol32110618
Ikeda, Masaomi; Fujimoto, Kiyohide; Miura, Noriyoshi; Taoka, Rikiya; Nishihara, Kiyoaki; Ikarashi, Daiki; Naito, Sei; Shimizu, Fumitaka; Fujihara, Atsuko; Shono, Michihiro; Nakagawa, Tohru; Kikuchi, Eiji
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Safety of Robot-Assisted Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Real-World Analysis Using the National Clinical Database in Japan

日本国家临床数据库真实世界分析：机器人辅助根治性膀胱切除术治疗肌层浸润性膀胱癌的安全性

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.71109
Hatakeyama, Shingo; Yamamoto, Hiroyuki; Kitamura, Hiroshi; Kamoto, Toshiyuki; Kikuchi, Eiji
肿瘤
肿瘤免疫
膀胱癌
发表日期：2025
文献求助 收藏

Avelumab Maintenance Therapy in Patients With Curatively Unresectable Urothelial Carcinoma in Japan: Subgroup Analyses of Post-Marketing Surveillance Data by Age, Prior Chemotherapy Regimen, and Best Overall Response to Prior Chemotherapy

在日本，对无法根治性切除的尿路上皮癌患者进行阿维鲁单抗维持治疗：按年龄、既往化疗方案和既往化疗最佳总体疗效进行上市后监测数据的亚组分析

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.71177
Nagata, Masayoshi; Kikuchi, Eiji; Ito, Taito; Sato, Masashi; Ogi, Mie; Morita, Makiko; Kajita, Masahiro; Nishiyama, Hiroyuki
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Real-World Outcomes of Avelumab Maintenance Therapy in Patients With Curatively Unresectable Urothelial Carcinoma in Japan: Results From the Final Analysis of Postmarketing Surveillance

日本不可切除尿路上皮癌患者接受阿维鲁单抗维持治疗的真实世界疗效：上市后监测最终分析结果

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.71264
Kikuchi, Eiji; Nagata, Masayoshi; Ito, Taito; Sato, Masashi; Ogi, Mie; Morita, Makiko; Kajita, Masahiro; Nishiyama, Hiroyuki
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏